
























![]()
Q1: 2026-05-05 Earnings Summary
EPS of -$0.03 beats by $0.11
|
Revenue of
$810.90M
(4.50% Y/Y)
beats by $12.97M
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call May 5, 2026 8:30 AM EDT
Company Participants
David Doherty - Executive VP & CFO
J. Evans - CEO & Director
Justin Oppenheimer - Executive Vice President, COO & National Group President
Conference Call Participants
Brian Tanquilut - Jefferies LLC, Research Division
Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division
Benjamin Hendrix - RBC Capital Markets, Research Division
Benjamin Mayo - Leerink Partners LLC, Research Division
Joanna Gajuk - BofA Securities, Research Division
Thomas Walsh - Barclays Bank PLC, Research Division
Sarah James - Cantor Fitzgerald & Co., Research Division
Albert Rice - UBS Investment Bank, Research Division
Will Spivack - TD Cowen, Research Division
William Sutherland - The Benchmark Company, LLC, Research Division
Benjamin Rossi - JPMorgan Chase & Co, Research Division
Presentation
Operator
Ladies and gentlemen, greetings, and welcome to the Surgery Partners First Quarter 2026 Earnings Conference Call.
[Operator Instructions]
As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Dave Doherty, Surgery Partners' Chief Financial Officer. Please go ahead.
David Doherty
Executive VP & CFO
Good morning, and thank you for joining Surgery Partners First Quarter 2026 Earnings Call. I am joined today by Eric Evans, our Chief Executive Officer; as well as Justin Oppenheimer, our Chief Operating Officer, who joined the company in January.
During this call, we will make forward-looking statements. There are risk factors that could cause future results to be materially different from these statements as described in this morning's press release and the reports we file with the SEC. The company does not undertake any duty to update these forward-looking statements. In addition, we reference certain non-GAAP financial measures, which we believe can be useful in evaluating our performance. We reconcile these measures to the most applicable GAAP measure in this morning's press release.
With
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。